Akers Biosciences, Inc. Purchase Agreements
11 Contracts & Agreements
- Form of Purchase Agreement (Filed With SEC on February 21, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on August 15, 2022)
- Asset Purchase Agreement, dated November 11, 2020, by and between MyMD Pharmaceuticals, Inc. and Supera Pharmaceuticals, Inc (Filed With SEC on May 18, 2021)
- Form of Securities Purchase Agreement, dated November 11, 2020, by and between Akers Biosciences, Inc. and purchasers named therein (Filed With SEC on November 12, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on August 13, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on May 15, 2020)
- Amendment No. 1 to the Membership Interest Purchase Agreement, dated May 14, 2020 (Filed With SEC on May 15, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on April 8, 2020)
- Membership Interest Purchase Agreement (Filed With SEC on March 24, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on November 29, 2019)
- Form of Securities Purchase Agreement, dated October 31, 2018, by and among the Company and the investors signatory thereto (Filed With SEC on October 31, 2018)
